MSCA

MSCA Postdoctoral Fellowships 2025: HORIZON-MSCA-2025-PF-01-01

Fellowships will be awarded to outstanding researchers pursuing international mobility. Applications must be submitted jointly by the researcher and a beneficiary entity from the academic or non-academic sector. Postdoctoral Fellowships can be undertaken in Europe (i.e., in an EU Member State or a Horizon Europe Associated Country) or in a third country not associated with Horizon Europe:

• European Postdoctoral Fellowships: They are open to researchers of any nationality who wish to participate in R&D&I projects, whether coming to Europe from anywhere in the world or moving within Europe. The standard duration of these fellowships is between 12 and 24 months.

• Global Postdoctoral Fellowships: These fellowships are open to European nationals or long-term residents who wish to participate in R&D&I projects with organizations outside the EU Member States and Horizon Europe Associated Countries. These fellowships require an initial period abroad of a minimum of 12 and a maximum of 24 months in a non-associated third country, and a mandatory 12-month return period to a host organization located in an EU Member State or a Horizon Europe Associated Country.

Closing date: 10/09/2025

MSCA Staff Exchanges 2025: HORIZON-MSCA-2025-SE-01-01

MSCA Staff Exchanges involve organisations from the academic and non-academic sectors (including SMEs) from all over the world.

Support is provided for the international, intersectoral and interdisciplinary mobility of staff. R+D which promotes the transfer of knowledge between participating organizations.

Mobility through stays

The organizations that form the association contribute directly to the implementation of a joint project of R+D by sending and/or hosting eligible staff. Such a project should explore activities that can build on previous work, but should also go beyond that, generating or strengthening long-term collaborations. The placements should involve physical mobility of eligible staff members and should always take place between legal entities independent of each other.

Closing date: 08/10/2025

MSCA AND Citizens: European Researchers' Night at Schools 2026-2027: HORIZON-MSCA-2025-CITIZENS-01-01

The MSCA and Citizenship event, also known as the European Researchers' Night, aims to bring research and the work of researchers closer to the general public, thus fostering a greater understanding of the role science plays in the development of society and its influence on our daily lives.

Closing date: 22/10/2025 at 17:XNUMX p.m.

ERC

ERC PROOF OF CONCEPT GRANT 2025

These calls are intended to verify the innovative potential of ideas and results derived from projects already funded by ERC projects that are under development or that have been completed during the year prior to the opening date of this call.

Learn more.

Closing date: 18/09/2025

ERC

ERC Starting Grant 2026

ERC-2026-StG: This call is open to talented researchers at the beginning of their research careers who have produced excellent supervised work, are prepared to work independently, and have the potential to become a research leader.

The official information of the call is available at this link.

Closing date: 14/10/2025

ERC

ERC Sinergy Grant 2026

ERC-2026-SyG: This call is open to a group of two to four Principal Investigators (PIs) to jointly address ambitious research problems that could not be addressed by individual PIs and their teams working alone.

The official information of the call is available in the following link.

Closing date: 05/11/2025

ERC

ERC Consolidator Grants 2025

ERC-2026-CoGThese grants are open to researchers of any nationality with 7-12 years of experience since completing their doctorate.

ERC Consolidator Grants are designed to support outstanding Principal Investigators who are at a stage in their career where they may still be consolidating their own independent research team or programme. Principal Investigators must demonstrate the innovative character, ambition and feasibility of their research proposal.

More information in this link.

Closing date: 13/01/2026

To support applications for these calls, the agency ERC has recorded the webinar on the basic concepts of the Work Programme (WP) 2026.

Cluster 1 Health - Single Stage

Destination - Tackling diseases and reducing disease burden

• HORIZON-HLTH-2025-01-DISEASE-01: Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections

  
  

• HORIZON-HLTH-2025-01-DISEASE-03:Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential

  
  

• HORIZON-HLTH-2025-01-DISEASE-04:Leveraging artificial intelligence for pandemic preparedness and response

  
  

• HORIZON-HLTH-2025-01-DISEASE-05:Support for the functioning of the Global Research Collaboration for InfectiousDisease Preparedness (GloPID-R)

  
  

• HORIZON-HLTH-2025-01-DISEASE-06: Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD)

  
  

• HORIZON-HLTH-2025-01-DISEASE-07: Tackling high-burden for patients and under-researched medical conditions

Destination - Ensuring equal access to innovative, sustainable, and high-quality healthcare

• HORIZON-HLTH-2025-01-CARE-01: End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU)

  
  

Destination - Developing and using new tools, technologies and digital solutions for a healthy society

• HORIZON-HLTH-2025-01-TOOL-01: Enhancing cell therapies with genomic techniques

  
  

• HORIZON-HLTH-2025-01-TOOL-02: Advancing cell secretome-based therapies

  
  

• HORIZON-HLTH-2025-01-TOOL-03: Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU)

  
  

• HORIZON-HLTH-2025-01-TOOL-05: Boosting the translation of biotech research into innovative health therapies

  
  

Destination - Maintaining an innovative, sustainable, and competitive EU health industry

• HORIZON-HLTH-2025-01-IND-01: Optimizing the manufacturing of Advanced Therapy Medicinal Products (ATMPs)

  
  

• HORIZON-HLTH-2025-01-IND-02: Digitalization of conformity assessment procedures of medical devices and in vitro diagnostic medical devices

  
  

Closing date: 16/09/2025

Cluster 1 Health - Two Stage

Destination - Living and working in a health-promoting environment

• HORIZON-HLTH-2025-03-ENVHLTH-01-two-stage: The impact of pollution on the development and progression of brain diseases and disorders

  
  

• HORIZON-HLTH-2025-03-ENVHLTH-02-two-stage: Advancing knowledge on the impacts of micro- and nanoplastics on human health

Destination - Tackling diseases and reducing disease burden

• HORIZON-HLTH-2025-03-DISEASE-02-two-stage: Advancing innovative interventions for mental, behavioral and neurodevelopmental disorders

  
  

  
  

Destination - Maintaining an innovative, sustainable, and competitive EU health industry

• HORIZON-HLTH-2025-03-IND-03-two-stage: Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices

  
  

Destination - Staying healthy in a rapidly changing society

• HORIZON-HLTH-2025-03-STAYHLTH-01-two-stage: Improving the quality of life of persons with intellectual disabilities and their families

  
  

Closing date for the first phase: 16/09/2025

Closing date for the second phase: 16/04/2026

CANCER MISSION WP2025

• HORIZON-MISS-2025-02-CANCER-01: Sustained collaboration of national and regional cancer funders to support the Cancer Mission through translational Research.

  
  

• HORIZON-MISS-2025-02-CANCER-02: Understanding the effects of environmental exposure on the risk of pediatric, adolescent and young adult cancers.

  
  

• HORIZON-MISS-2025-02-CANCER-03: Innovative surgery as the cornerstone of affordable multi-modal therapeutic interventions benefiting cancer patients with locally advanced or metastatic disease.

  
  

• HORIZON-MISS-2025-02-CANCER-04: Investigator-initiated multinational early-stage innovative clinical trials for pediatric cancer.

  
  

• HORIZON-MISS-2025-02-CANCER-05: Pragmatic clinical trials to enhance the quality of life of older cancer patients (65 years and older) through nutrition.

  
  

• HORIZON-MISS-2025-02-CANCER-06: Support to the network of National Cancer Mission Hubs (NCMHs).

  
  

Closing date: 16/09/2025

EIC

EIC Transition Open 2025

HORIZON-EIC-2025-TRANSITIONOPEN:

EIC Transition funds innovation activities that go beyond the experimental proof of concept in the laboratory. It supports both the maturation and validation of your novel technology, from the laboratory to relevant application environments (through the use of prototypes, formulations, models, user trials, or other validation tests), as well as the exploration and development of a sustainable business model and business case for commercialization.

Deadline: 17 / 09 / 2025

EIC Pathfinder Challenged Open

HORIZON-EIC-2025-PATHFINDERCHALLENGES-01 02): Generative-AI based Agents to Revolutionize Medical Diagnosis and Treatment of Cancer.

Closing date: 29/10/2025

IHI

IHI call 11:

The main objectives of the European partnership, the Innovative Health Initiative (IHI), are to translate health research and innovation into tangible benefits for patients and society, and to ensure that Europe remains at the forefront of interdisciplinary, sustainable, and patient-centered health research.

The 11th round of this partnership is being developed in two stages, with topics covering brain dysfunction, the relationship between infections and noncommunicable diseases, pharmacovigilance, type 1 diabetes, and outpatient surgical centers.

More Information.

Closing date for the first phase: 09/10/2025

Closing date for the second phase: 29/04/2026

PerMed

EP PerMed. “Education Call: Guide to Personalized Medicine for Healthcare Professionals”

The objective of this call is to provide funding to support the provision and development of educational content for healthcare professionals in the implementation of personalized medicine.

• Financing: max. €50.000 (indirect costs included).

  
  

Learn more.

Closing date: 09/09/2025

EP PerMed: Networking Support Call (NSC) 2025: Networking opportunity for preciously funded projects in personalized medicine

The objective of this call is to create networks in the field of personalized medicine, with the aim of promoting the translation and application of research results into clinical practice.

• Financing: max. €30.000.

More Information.

Closing date: 29/09/2025

EP PerMed: Research Innovation an Technology Call for Proposals (RITC) 2026

Test and Demonstration of Multimodal Data Approaches for Personalized Medicine (MultiPMData2026)

This call seeks to bring together companies and clinical stakeholders (healthcare providers, patients, and researchers) to test innovative solutions in controlled, real-world settings, with the goal of improving the management of multimorbidity.

EP PerMed will fund projects focused on the use of multimodal data to provide more efficient and personalized management for patients with at least two chronic diseases. Projects must test and develop mature solutions in real-world settings, adopt a systemic approach, and integrate six key elements (knowledge, technology, infrastructure, business models, policies, organization, and values). Proposals must include a clear strategy for multimodal health data management.

Consortia must have a clinical partner and at least one SME or industrial partner. Clinical studies can be funded, but not large clinical trials.

Call for applications publication date: early October 2025

Closing date for the first phase: 12/01/2026

Closing date for the second phase: 27/04/2026

NEURON

ERA-NET NEURON Award: Excellent Paper in Neuroscience

The European joint initiative in neurological research, NEURON, is launching a prize to recognize the best publication by an outstanding scientist in the early stages of their career. The article must have been published between January 1 and December 31, 2024.

The award focuses on research related to the mechanisms of resilience and vulnerability to environmental challenges in mental health.

Financial endowment: 3.000 euros

Learn more.

Closing date: 15/10/2025

COST

COSTAction

COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks. Its actions help connect research initiatives across Europe and beyond, and allow researchers and innovators to develop their ideas in any field of science and technology by sharing them with their peers.

Participants planning to submit a proposal for a COST Action should refer to the SESA guidelines and the Open Call Announcement, available on the COST Action page. Documents and Guidelines.

Closing date: 21/10/2025

CERIC

Research Infrastructures - CERIC-ERIC

The Central European Research Infrastructure Consortium (CERIC-ERIC) is launching a call for proposals for coordinated access to more than 60 research support facilities and laboratories in all fields of materials, biomaterials, and nanotechnology. The call is open to researchers worldwide. In addition to the possibility of accessing multiple facilities through a single application, mobility support is also available.

To submit your application, please use the link "Submit a new CERIC proposal" in the Virtual Unified Office (VUO), at https://vuo.elettra.trieste.it/

More training

Closing date: 01/10/2025 at 17h CEST (final submission), recommended only for users who are experts in all the requested techniques.

EU4Health

Commission adopts EU4Health Work Programme 2025

The Commission has adopted the EU4Health Work Programme (WP), which sets out the strategic policy orientations for 2025.

WP 2025 supports EU health priorities, aiming to protect citizens and foster innovation in Europe.

Focus areas include cardiovascular health, digital health, cancer, health technology assessment, crisis preparedness, medicines and medical devices, and human-derived substances.

More Information

The Global Grants for Gut Health

Global Grants for Gut Health is a competitive funding initiative that supports innovative, investigator-led research focused on the human gut microbiota. This program, jointly supported by Yakult and Nature Portfolio, aims to advance scientific knowledge about the fundamental role the gut microbiome plays in human health.

Proposals for research projects are invited. one year duration, which may include both laboratory research and clinical studies, and which explore the role of Nutrition in the modulation of the human gut microbiome and intestinal barrier functionStudies that analyze the interaction between diet, microbial composition, and intestinal barrier homeostasis will be especially encouraged. The detailed scope can be found on the website. For Applicants.

Selected projects must demonstrate scientific rigor, originality or with a significant potential to contribute to the advancement of the field of microbiome research.

Closing date: 09/09/2025

Alzheimer's Drug Discovery Foundation

Drug Development RFP

the summons Drug Development RFP supports studies necessary for the obtaining authorization for early-phase clinical trials (qualifying studies for the application of a Investigational New Drug – IND, or its international equivalent), as well as early-phase clinical trials to evaluate promising pharmacological interventions and devices for Alzheimer's disease (AD) and other related dementias.

This funding opportunity focuses on diverse pharmacological mechanisms and modes of action related to biology of aging and other emerging therapeutic areas in the field of dementia.

More Information here

Cover letter closing date: 15/09/2025

Full proposal closing date: 17/11/2025

The Brain Tumour Charity

Expanding Theories 2025/2

Financing of up to £75.000 per year is available for a maximum of 2 years.

This call supports pilot studies that explore and develop novel concepts that could eventually lead to significant improvements in clinical outcomes, including quality of life, for people with brain tumors.

Proposals that explore innovative approaches that could fundamentally transform our understanding, diagnosis, and/or management of brain tumors will also be considered.

The objective of this call is to generate sufficient data to support future applications for larger-scale projects to national or international funding agencies. This call does not fund clinical trials.

More Information here

Deadline: 24 / 09 / 2025

BrightFocus Foundation

Alzheimer's Disease Research Request for Proposals

Alzheimer's Disease Research, a program of the Bright Focus Foundation, provides research funding to scientists both in the United States and abroad who are conducting pioneering research aimed at better understanding, preventing, and treating Alzheimer's disease.

They are committed to supporting scientists from diverse backgrounds to foster creativity and innovation in addressing complex scientific challenges, and strongly encourage applications from individuals from groups underrepresented in Alzheimer's disease research.

More Information here

Deadline: 29 / 09 / 2025

16-17/09/2025

European Research and Innovation Days 2025

Organized by the European Commission, the European Research and Innovation Days will bring together researchers, entrepreneurs, policymakers, business leaders, and other key stakeholders in the European research and innovation ecosystem. The objective will be to discuss how research and innovation contribute to strengthening Europe's competitiveness, sustainability, and industrial leadership, in line with the European Union's main priorities. This sixth edition comes at a crucial time for discussions on the next long-term EU budget and the political priorities of the current European Commission.

The event can be followed both in person in Brussels and online.

More Information

26-27/09/2025

European Researchers' Night

The Aragón Health Research Institute (IIS Aragón) participates in the European Researchers' Night, which is being held this year on September 26 and 27 in Zaragoza.

The objectives The aims of this event are to show the more human side of science, to bring the figure of researchers closer to the public so that they know their work and the benefits it brings to society, as well as to foster curiosity and interest in what surrounds us, awaken scientific vocations by encouraging the choice of a scientific career among students, eliminating gender barriers.

02/10/2025

Advanced course on longread sequencing and medical genomics

The European project EASIGEN-DS (DesignStudy for a Research Infrastructure on Advanced Genomics Technologies, GA101187908) co-organizes the free course Advanced course on long-readsequencing and medical genomics in Leuven, which will bring together international experts to explore the latest developments in long-term technologies and their medical and clinical research applications. It is aimed at doctoral students and postdocs.

• Register here.

• Events.

28/10/2025

EACR-OECI: Patient Involvement in Cancer Research

The patient perspective in cancer research is vital to creating more effective, compassionate, and equitable research that truly benefits those affected by the disease. Patient focus organizations are working on empowering patients to actively participate in decision-making, treatment planning, and research design, fostering better outcomes and relevance, but there is still work to be done.

By actively incorporating patients' perspectives, research can better address key aspects of cancer care, such as patients' quality of life, symptom management, and treatment side effects. Patients can also highlight gaps in communication and in current treatment options or areas where existing therapies fall short, leading to the development of innovative approaches to care.

This virtual event, a collaboration between theEACR and the OECI (Organisation of European Cancer Institutes), will explore how meaningful involvement of cancer advocates throughout the research process can lead to impactful cancer research.

More Information

28/10/2025

PerMed RITC2026

The European Association for Personalized Medicine (EP Per Med), within the framework of Horizon Europe, will hold an information day to present the first Research, Innovation and Technology Call (RITC2026) to the research community in an online format.

The objectives of the call, the planned timeline, and the conditions for participation will be detailed during the session. This initiative is part of the implementation of the Strategic Research and Innovation Agenda (SRIA) for Personalized Medicine (2023).

Learn more.